Log in

NASDAQ:PMD - Psychemedics Stock Price, Forecast & News

$9.25
+0.05 (+0.54 %)
(As of 02/17/2020 03:55 AM ET)
Add
Today's Range
$9.15
Now: $9.25
$9.30
50-Day Range
$9.00
MA: $9.59
$10.62
52-Week Range
$7.12
Now: $9.25
$19.64
Volume13,249 shs
Average VolumeN/A
Market CapitalizationN/A
P/E Ratio33.04
Dividend Yield7.83%
BetaN/A
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time. It provides screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, synthetic cannabinoids, and benzodiazepines, as well as opiates, including heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine. The company offers its services to employers for applicant and employee testing; treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use; and Fortune 500 companies and small to mid-size corporations, as well as school and government entities. Psychemedics Corporation was founded in 1985 and is headquartered in Acton, Massachusetts.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:PMD
CUSIPN/A
WebN/A
PhoneN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees250
Next Earnings Date4/28/2020 (Estimated)
OptionableNot Optionable

Receive PMD News and Ratings via Email

Sign-up to receive the latest news and ratings for PMD and its competitors with MarketBeat's FREE daily newsletter.


Psychemedics (NASDAQ:PMD) Frequently Asked Questions

What is Psychemedics' stock symbol?

Psychemedics trades on the NASDAQ under the ticker symbol "PMD."

How often does Psychemedics pay dividends? What is the dividend yield for Psychemedics?

Psychemedics announced a quarterly dividend on Tuesday, February 11th. Investors of record on Friday, February 21st will be given a dividend of $0.18 per share on Tuesday, March 3rd. This represents a $0.72 annualized dividend and a dividend yield of 7.78%. The ex-dividend date is Thursday, February 20th. View Psychemedics' Dividend History.

How were Psychemedics' earnings last quarter?

Psychemedics Corp. (NASDAQ:PMD) announced its quarterly earnings data on Tuesday, April, 23rd. The company reported $0.11 earnings per share for the quarter. The business had revenue of $9.82 million for the quarter. View Psychemedics' Earnings History.

When is Psychemedics' next earnings date?

Psychemedics is scheduled to release their next quarterly earnings announcement on Tuesday, April 28th 2020. View Earnings Estimates for Psychemedics.

Has Psychemedics been receiving favorable news coverage?

News headlines about PMD stock have trended somewhat positive this week, according to InfoTrie. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Psychemedics earned a media sentiment score of 1.8 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Psychemedics.

Are investors shorting Psychemedics?

Psychemedics saw a decline in short interest in the month of January. As of January 31st, there was short interest totalling 6,800 shares, a decline of 41.4% from the January 15th total of 11,600 shares. Based on an average trading volume of 22,100 shares, the short-interest ratio is presently 0.3 days. Currently, 0.1% of the company's stock are short sold. View Psychemedics' Current Options Chain.

What other stocks do shareholders of Psychemedics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Psychemedics investors own include Zynerba Pharmaceuticals (ZYNE), AT&T (T), AbbVie (ABBV), Dominion Energy (D), Athersys (ATHX), Corbus Pharmaceuticals (CRBP), Gilead Sciences (GILD), Pattern Energy Group (PEGI), TrovaGene (TROV) and Verastem (VSTM).

Who are Psychemedics' key executives?

Psychemedics' management team includes the folowing people:
  • Mr. Raymond C. Kubacki Jr., Chairman, CEO & Pres (Age 74)
  • Mr. Neil Lerner, VP of Fin. & Treasurer (Age 51)
  • Dr. Michael I. Schaffer, VP of Laboratory Operations (Age 74)
  • Dr. Werner A. Baumgartner Ph.D., Founder
  • Ms. Annette Baumgartner, Founder

Who are Psychemedics' major shareholders?

Psychemedics' stock is owned by a number of of institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (8.61%), Tieton Capital Management LLC (6.06%), Blair William & Co. IL (1.29%), Ancora Advisors LLC (1.12%), North Star Investment Management Corp. (1.08%) and NEXT Financial Group Inc (0.07%). Company insiders that own Psychemedics stock include Charles M Doucot, Michael I Schaffer, Neil Lerner and Raymond C Kubacki Jr. View Institutional Ownership Trends for Psychemedics.

Which major investors are selling Psychemedics stock?

PMD stock was sold by a variety of institutional investors in the last quarter, including North Star Investment Management Corp. and Blair William & Co. IL. Company insiders that have sold Psychemedics company stock in the last year include Michael I Schaffer and Neil Lerner. View Insider Buying and Selling for Psychemedics.

Which major investors are buying Psychemedics stock?

PMD stock was acquired by a variety of institutional investors in the last quarter, including Ancora Advisors LLC, Renaissance Technologies LLC, Tieton Capital Management LLC and NEXT Financial Group Inc. Company insiders that have bought Psychemedics stock in the last two years include Charles M Doucot and Raymond C Kubacki Jr. View Insider Buying and Selling for Psychemedics.

How do I buy shares of Psychemedics?

Shares of PMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Psychemedics' stock price today?

One share of PMD stock can currently be purchased for approximately $9.25.


MarketBeat Community Rating for Psychemedics (NASDAQ PMD)

Community Ranking:  3.0 out of 5 (star star star)
Outperform Votes:  133 (Vote Outperform)
Underperform Votes:  86 (Vote Underperform)
Total Votes:  219
MarketBeat's community ratings are surveys of what our community members think about Psychemedics and other stocks. Vote "Outperform" if you believe PMD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PMD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/17/2020 by MarketBeat.com Staff

Featured Article: Float

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel